Safety of Semaglutide.
Smits MM, Van Raalte DH.
Front Endocrinol (Lausanne). 2021 Jul 7;12:645563. doi: 10.3389/fendo.2021.645563. eCollection 2021.
Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study.
Chen J, Yuan S, Fu T, Ruan X, Qiao J, Wang X, Li X, Gill D, Burgess S, Giovannucci EL, Larsson SC.
Diabetes Care. 2023 Apr 1;46(4):828-835. doi: 10.2337/dc22-1385.
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials.
Nreu B, Dicembrini I, Tinti F, Mannucci E, Monami M.
Minerva Endocrinol (Torino). 2023 Jun;48(2):206-213. doi: 10.23736/S2724-6507.20.03219-8. Epub 2020 Jul 23.
Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis.
Tan HC, Dampil OA, Marquez MM.
J ASEAN Fed Endocr Soc. 2022;37(2):65-72. doi: 10.15605/jafes.037.02.14. Epub 2022 Aug 23.
Adverse Effects of GLP-1 Receptor Agonists.
Filippatos TD, Panagiotopoulou TV, Elisaf MS.
Rev Diabet Stud. 2014 Fall-Winter;11(3-4):202-30. doi: 10.1900/RDS.2014.11.202. Epub 2015 Feb 10.
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus.
Deacon CF.
Nat Rev Endocrinol. 2020 Nov;16(11):642-653. doi: 10.1038/s41574-020-0399-8. Epub 2020 Sep 14.
Depression and 24 gastrointestinal diseases: a Mendelian randomization study.
Ruan X, Chen J, Sun Y, Zhang Y, Zhao J, Wang X, Li X, Yuan S, Larsson SC.
Transl Psychiatry. 2023 May 4;13(1):146. doi: 10.1038/s41398-023-02459-6.
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators.
N Engl J Med. 2013 Oct 3;369(14):1317-26. doi: 10.1056/NEJMoa1307684. Epub 2013 Sep 2.
Type 3c: Understanding pancreatogenic diabetes.
Vonderau JS, Desai CS.
JAAPA. 2022 Nov 1;35(11):20-24. doi: 10.1097/01.JAA.0000885140.47709.6f.
Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update.
Bhattamisra SK, Siang TC, Rong CY, Annan NC, Sean EHY, Xi LW, Lyn OS, Shan LH, Choudhury H, Pandey M, Gorain B.
Curr Diabetes Rev. 2019;15(5):382-394. doi: 10.2174/1573399815666190115145702.
